Experts on a US panel expressed their doubts on the beneficial quality of prostate cancer screenings for elderly men. Prostate cancer often grows very slowly and may not kill an older man before he suffers from another death reason, they pointed out.
From September onwards, Europe's largest academic health science partnership will start its programm in London, UK. Their focus will lay on preventing and treating major diseases in 10 key areas.
A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA.
They are one of the major threats in today's hospital: tiny pathogens that hide out in catheters, in ventilation tubes, on instruments or on the keyboards of medical technological equipment only waiting to attack patients whose immune system is already weakened. This week, EH Online will take a closer look at nosocomial infections, their causes, their effects and the available ways and means to…
B. Braun Melsungen AG laid the foundation stone for a new manufacturing plant for production and development in nutrition solutions. The new production site includes a research lab and costs around 190 million Euro. In the future 270 employees will work on innovative denouements for the world market.
Almost all stomach cancers not related to the heart develop from the stomach ulcer causing bug H. pylori. A Japanese study shows that treatment to eradicate the mikrobe reduces the risk of developing new gastric carcinoma in patients.
An international panel of physicians has updated the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection after evaluating recent data, according to an article in JAMA, a theme issue on HIV/AIDS.
As rocks keep the secrets of the earth, bones might keep those of the body. A new study that will be publish in the September 1, 2008 issue of CANCER suggests, that factors responsible for higher bone mineral density might also lead to higher risk of breast cancer.
In any hospital, one of the most dreaded enemies is MRSA. This super-resistant pathogen laughs in the face of most antibiotics. But now, medical and hygiene product manufacturer Lohmann & Rauscher may have developed an efficient weapon to fight this ugly beast: a wound dressing that contains polyhexamethylene biguanide (PHMB).
Reseacher from the Univerisity of Zürich discovered a new function of the “happiness hormone”, serotonin. It boosts the growing of colon cancer by enhancing the vascular development of tumors.
Even in 2004, the medical costs for the care of stroke patients in Germany came to 7.1 billion euro. The neurologist Tobias Neumann-Haefelin of the Johann Wolfgang Goethe University in Frankfurt and his colleagues have calculated the projected number of strokes in the German federal state of Hesse for the year 2050.
Last month Agendia announced the official opening of the company's new headquarters at Amsterdam's Science Park. The new facilities offer 13,000 square feet of laboratory and office space to support the company's molecular diagnostic cancer testing services and research activities.
This week not only one but rather two studies report about a new and independent marker that is associated with type 2 diabetes. The protein that is called fetuin-A is produced in the liver and secreted to the blood stream also indicates a higher risk of developing diabetes disease.
Answer: Older men, living in high social deprivation who are treated for pain or infectious diseases are very endangered. That is the simplified result Scottish researchers investigated while trying to point out criterias that might predict the likelihood of emergency admission in adults older than 40 years
High-Density-Lipoprotein-Cholesterol is a so-called "good" cholestoral because it seems to protect the vessels from fat deposits. Hereby they can prevent atherosclerosis. The Whitehall II Study in the UK searched for the specific connection between low level of HDL and dementia risk and published now their results.
Scientists have identified about two dozen genes that control embryonic stem cell fate. The genes may either prod or restrain stem cells from drifting into a kind of limbo, they suspect. The limbo lies between the embryonic stage and fully differentiated, or specialized, cells, such as bone, muscle or fat.
The ratio between the concentrations of metabolites may give the answer to the question. Researchers at the Helmholtz Zentrum in Munich demonstrated the proof of principle. They identified diabetic or healthy mice by biomarkers they analyzed only by bioinformatics. Metabolomics might permit a promising tool for pre-clinical investigation of effects and side effects of new drugs, they say.
Limited public and political awareness of colorectal cancer (CRC), few formal screenings programms, delayed access to treatment - the first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients in Europe and Australia.
The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Now a molecular genetics research team around Prof Naama Barkai found out that an inhibitor molecule channels the morphogenic substances within the injured embryo so that new growing tissues and organs are developing in the right proportions.
Little research has been carried out into new therapies for wound healing. As chronic wounds tend to be classed as side effects of other diseases, e.g. diabetes, they are often treated as trivial. However, the body's capacity to heal itself often does not set in for weeks.
Hair follicles, long disregarded by researchers, except in the cosmetic industry, may turn out to be `the fountain of youth´, according to Andreas Emmendörffer, CEO of German biotech firm Euroderm.
This was it, 15th May, the big day: Johnson & Johnson's Worldwide Mesh Technology Centre was officially opening in Norderstedt near Hamburg, Germany.
Italy - The genome sequence of Acinetobacter baumannii has been determined by scientists at the Istituto di Tecnologie Biomediche, the Dipartimento di Malattie Infettive at the Istituto Superiore della Sanità and the Dipartimento di Biologia at Roma Tre University. In Italy alone this antibiotic resistant pathogen causes 4,500 to 7,000 deaths annually.
Along with MRSA and ESBL bacteria, Clostridium difficile is causing a growing problem. Epidemics of a new C. difficile strain have already occurred in hospitals in North America, England and the Benelux countries.
Three companies that have pioneered development of new sequencing technologies have joined the 1000 Genomes Project - the international research consortium, announced in January, aiming to build the most detailed map of human genome that will provide a view of biomedically relevant DNA variations at a resolution unmatched by current resources.
